Get the Latest Investment Ideas Delivered Straight to Your Inbox.

Seachange in Mexico on Cannabis Could Benefit This Small Cap
Contributed Opinion

Source:

Technical analyst Clive Maund highlights a small-cap that may be poised to benefit from the recent Mexican Supreme Court decision on cannabis.

Although there is little net change in Captiva Verde Land Corp. (PWR:CSE) since we last looked at it just over a month ago, its technical condition has continued to improve. The reason for saying this is the appearance of heavy upside volume on the sharp rally late last month that has driven the Accumulation line to new highs, as we can see on the latest 1-year chart below.

There was a slightly disconcerting dip in the middle of last month, but key support held and as a result of that move we must now consider the Right Shoulder of the prospective Head-and-Shoulders bottom to be this dip, rather than the minor one early in September. Otherwise the interpretation of the overall pattern remains the same—positive, and as mentioned above the high volume on the latest sharp rally bodes well. Latest action suggests that it is building up to something, and with a small countertrend Flag looking like it is completing, it is suspected that it is getting ready to break out above the resistance level at C$0.30.


With respect to fundamental considerations, you may recall that Captiva Verde is in possession of licenses to do business in Mexico, a potentially huge market, and thus the news that the Mexican Supreme Court has decreed that cannabis could no longer be classified as an illegal substance means that they have in effect legalized it, which is really big news in a country that has three times the population of Canada and is also blessed with ideal growing conditions. So in future it will be possible for cannabis farmers to make money legally from the crop. The ruling from the Supreme Court ends the blanket ban on cannabis in Mexico and starts the ball rolling in the direction of legalization, which will take time as all the peripheral legislation will have to be passed. Nevertheless this sea change should provide a big boost to cannabis companies and stocks operating in Mexico or preparing to do so.

We therefore stay long and the stock is rated a strong buy at this juncture. There are 87.6 million shares in issue and the stock trades in improving volumes on the U.S. OTC market where as ever limit orders should be employed.

Captiva Verde Land Corp., PWR.CSX, CPIVF on OTC, trading at C$0.23, $0.17 on 8th November 2019.

Originally posted on cliveMaund.com at 8.40 am EST on 11th November 2019.

Clive Maund has been president of www.clivemaund.com, a successful resource sector website, since its inception in 2003. He has 30 years' experience in technical analysis and has worked for banks, commodity brokers and stockbrokers in the City of London. He holds a Diploma in Technical Analysis from the UK Society of Technical Analysts.

[NLINSERT]

Disclosure:
1) Clive Maund: I, or members of my immediate household or family, own shares of the following companies mentioned in this article: None. I personally am, or members of my immediate household or family are, paid by the following companies mentioned in this article: None. My company has a financial relationship with the following companies mentioned in this article: None. CliveMaund.com disclosures below. I determined which companies would be included in this article based on my research and understanding of the sector.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Statements and opinions expressed are the opinions of the author and not of Streetwise Reports or its officers. The author is wholly responsible for the validity of the statements. The author was not paid by Streetwise Reports for this article. Streetwise Reports was not paid by the author to publish or syndicate this article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
4) This article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Captiva Verde, a company mentioned in this article.

Charts provided by the author.

CliveMaund.com Disclosure:
The above represents the opinion and analysis of Mr Maund, based on data available to him, at the time of writing. Mr. Maund's opinions are his own, and are not a recommendation or an offer to buy or sell securities. Mr. Maund is an independent analyst who receives no compensation of any kind from any groups, individuals or corporations mentioned in his reports. As trading and investing in any financial markets may involve serious risk of loss, Mr. Maund recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction and do your own due diligence and research when making any kind of a transaction with financial ramifications. Although a qualified and experienced stock market analyst, Clive Maund is not a Registered Securities Advisor. Therefore Mr. Maund's opinions on the market and stocks can only be construed as a solicitation to buy and sell securities when they are subject to the prior approval and endorsement of a Registered Securities Advisor operating in accordance with the appropriate regulations in your area of jurisdiction.

Want to read more about Cannabis and Biotechnology / Pharmaceuticals investment ideas?
Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe